We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Clear all

Refine your search

Content type

Tags

Author

74 results found

Article

McDermott Will & Emery | USA | 31 May 2019

Corporate Law & Governance Update - May 2019

The Board’s nominating committee will benefit from an overview of The Conference Board’s important new survey on board composition, turnover and

Article

McDermott Will & Emery | USA | 8 Mar 2019

Massachusetts’ Highest Court Upholds Record Fine Against Beer Distributor for Pay-To-Play Scheme But Overturns Fine for Bar that Accepted Kickbacks

Last week, the Massachusetts Supreme Judicial Court upheld a $2.6 million fine against beer wholesaler Craft Brewers Guild (a Sheehan family-owned

Article

McDermott Will & Emery | USA | 11 Apr 2017

New OIG Rules Change Patient Incentive Program Landscape: Where Are the Limits Now?

With health care becoming more consumer-driven, many health care providers and health plans are wrestling with how to incentivize patients to

Article

McDermott Will & Emery | USA, Mexico | 19 Feb 2014

New energy opportunities in Mexico raise FCPA, anti-bribery risks

Sweeping reforms across Mexico’s oil, gas and electric markets promise more opportunities for the private sector and increased investment from

Article

McDermott Will & Emery | China | 13 Feb 2014

China compliance update: commercial bribery risks remain very real in China

The enactment of new legislation, as well as new and continuing investigations, demonstrates that Chinese regulators have not slowed down their

Article

McDermott Will & Emery | USA, China | 3 Sep 2013

China intensifies scrutiny of multinational pharmaceutical companies

The Chinese government's recent crackdown on alleged bribery and corruption of local officials by multinational pharmaceutical companies could signal

Article

McDermott Will & Emery | USA, China | 29 Aug 2013

Whistleblowing in China and the United States

Recent events in China underscore the importance of dealing effectively with whistleblowers. The Chinese Government's wide-ranging bribery and

Article

McDermott Will & Emery | China | 26 Jul 2013

Observations on a milestone bribery investigation and increased scrutiny of foreign companies in China

The Chinese government's recent crackdown on alleged bribery and corruption of local officials by multinational pharmaceutical companies could signal

Article

McDermott Will & Emery | USA | 14 Nov 2012

Corporate buyers beware: FCPA successor liability a growing threat

The threat of Foreign Corrupt Practices Act successor liability is a growing concern for U.S. buyers in cross-border deals.

Article

McDermott Will & Emery | Global | 16 Jul 2012

Corporate reporting on anti-bribery and corruption measures

Transparency International (TI), the global organisation against corruption, has published a policy study, Transparency in Corporate Reporting: Assessing the World's Largest Companies.

Previous page 1 2 3 ...